Asthma Clinical Trial
Official title:
Using Computers to Assist in the Treatment of Asthma in a Pediatric Setting
This study seeks to improve physician adherence to four recommendations of the NHLBI asthma
treatment guidelines:
1. Improve case detection of asthma among patients with pulmonary symptoms,
2. Grade all asthma patients asthma, identifying those with persistent versus intermittent
asthma,
3. Improve rates of use of controller medications - particularly inhaled steroids - among
patients with persistent asthma,
4. Provide an asthma treatment plan for all asthma patients.
Objectives: Improve physician adherence to four recommendations of the NHLBI asthma
treatment guidelines:
1. Improve case detection of asthma among patients with pulmonary symptoms,
2. Grade all asthma patients asthma, identifying those with persistent versus intermittent
asthma,
3. Improve rates of use of controller medications - particularly inhaled steroids - among
patients with persistent asthma,
4. Provide an asthma treatment plan for all asthma patients.
Design: This will be a randomized controlled trial. Patients registering for appointments at
the PCC Pediatric clinic will be randomized to an intervention or control arm. Patients in
the intervention arm, and the physicians who see them, will receive the full intervention.
Patients in the control arm will receive usual care.
Intervention: The CHICA computer system has been in regular use at the PCC Pediatrics clinic
since November 4, 2004. At patient check-in, CHICA produces a health survey that parents
complete in the weighting room. The survey is scanned into CHICA before the physician
encounter. CHICA produces a worksheet for the physician that includes prompts and reminders
based date from the health survey and the electronic medical record. The completer worksheet
is scanned back into CHICA. Intervention and control groups will continue to use this system
In the intervention group, CHICA will include a question asking for the presence of asthma
or asthma symptoms on the health survey. If the family responds that asthma or symptoms of
asthma are present, CHICA will:
1. Alert the physician and ask him or her to confirm or deny the presence of asthma and to
rate the asthma as persistent or intermittent,
2. Generate a chart showing the criteria for each asthma grade,
3. Recommend controller medications if the patient has persistent asthma and ask the
physician to document if controllers were prescribed,
4. Generate a partially completed treatment plan for the physician to complete and give to
the patient.
For patients confirmed to have asthma, CHICA will place a question on the health survey at
subsequent visits that assesses symptoms. For patients who have been prescribed controller
medications, CHICA will put a question on the health survey asking about patient adherence
to the medication. The physician worksheet will alert the physician to changes in the
patient's symptom status or to non-adherence to controller medication, in compliance with
NHLBI guidelines.
Outcome Measures: To determine the rates of asthma case finding in the intervention and
control groups, we will pull the RMRS electronic records of all patients seen during the
first 6 months of the trial and determine the prevalence of diagnoses for asthma (ICD-9 code
equal to 493.*).
After 6 months of running the trial, we will randomly select from those patients in the
trial who have an ICD-9 diagnosis of asthma (493.*), 75 patients from the intervention group
and 75 patients from the control group. The paper "shadow" charts for these patients will be
pulled from the chart room at the PCC Pediatrics clinic. Trained chart reviewers will
document the following:
1. Has the patient's asthma been graded as intermittent or persistent?
2. Is there documentation of an asthma treatment plan?
3. Has the patient been prescribed a controller medication?
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|